CROFAB

This brand name is authorized in United States

Active ingredients

The drug CROFAB contains a combination of these active pharmaceutical ingredients (APIs):

1 Snake venom antiserum
UNII RBR61YAJ4V - CROTALUS ATROX IMMUNE FAB ANTIVENIN (OVINE)

Snake venom antiserum contains venom-specific F(ab')2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body.

2 Snake venom antiserum
UNII IA6O0K772M - AGKISTRODON PISCIVORUS IMMUNE FAB ANTIVENIN (OVINE)

Snake venom antiserum contains venom-specific F(ab')2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body.

3 Snake venom antiserum
UNII 7WZ1744G86 - CROTALUS SCUTULATUS IMMUNE FAB ANTIVENIN (OVINE)

Snake venom antiserum contains venom-specific F(ab')2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body.

4 Snake venom antiserum
UNII A4229A7019 - CROTALUS ADAMANTEUS IMMUNE FAB ANTIVENIN (OVINE)

Snake venom antiserum contains venom-specific F(ab')2 fragments of immunoglobulin G (IgG) that bind and neutralize venom toxins, facilitating redistribution away from target tissues and elimination from the body.

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 50633-110

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.